Scholars@Duke

Glucose-Lowering Effects of DPP-4 Inhibitors Require beta-Cell Incretin Receptors

Publication ,  Conference
Capozzi, ME; D'Alessio, DA; Campbell, J
Published in: DIABETES
June 1, 2017
Link to item

Duke Scholars

David A D'Alessio
Author David A D'Alessio Medicine, Endocrinology, Metabolism, and Nutrition

Published In

DIABETES

EISSN

1939-327X

ISSN

0012-1797

Publication Date

June 1, 2017

Volume

66

Start / End Page

LB93 / LB93

Publisher

AMER DIABETES ASSOC

Related Subject Headings

  • Endocrinology & Metabolism
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Capozzi, M. E., D’Alessio, D. A., & Campbell, J. (2017). Glucose-Lowering Effects of DPP-4 Inhibitors Require beta-Cell Incretin Receptors. In DIABETES (Vol. 66, pp. LB93–LB93). AMER DIABETES ASSOC.
Capozzi, Megan E., David A. D’Alessio, and Jonathan Campbell. “Glucose-Lowering Effects of DPP-4 Inhibitors Require beta-Cell Incretin Receptors.” In DIABETES, 66:LB93–LB93. AMER DIABETES ASSOC, 2017.
Capozzi ME, D’Alessio DA, Campbell J. Glucose-Lowering Effects of DPP-4 Inhibitors Require beta-Cell Incretin Receptors. In: DIABETES. AMER DIABETES ASSOC; 2017. p. LB93–LB93.
Capozzi, Megan E., et al. “Glucose-Lowering Effects of DPP-4 Inhibitors Require beta-Cell Incretin Receptors.” DIABETES, vol. 66, AMER DIABETES ASSOC, 2017, pp. LB93–LB93.
Capozzi ME, D’Alessio DA, Campbell J. Glucose-Lowering Effects of DPP-4 Inhibitors Require beta-Cell Incretin Receptors. DIABETES. AMER DIABETES ASSOC; 2017. p. LB93–LB93.

Published In

DIABETES

EISSN

1939-327X

ISSN

0012-1797

Publication Date

June 1, 2017

Volume

66

Start / End Page

LB93 / LB93

Publisher

AMER DIABETES ASSOC

Related Subject Headings

  • Endocrinology & Metabolism
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences